Mammographic breast density during hormone replacement therapy: Differences according to treatment

American Journal of Obstetrics and Gynecology

Volumn 181, Issue 2, 1999, Pages 348-352

  Lundström, Eva ^a   Wilczek, Brigitte ^a   Von Palffy, Zoltan ^b   Söderqvist, Gunnar ^a   Von Schoultz, Bo ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b Höglandssjukhuset ^*  (Sweden)

Author keywords

Breast density; Hormone replacement therapy; Mammographic changes

Indexed keywords

ESTROGEN; PROGESTERONE;

BREAST; BREAST CANCER; BREAST CARCINOGENESIS; CANCER RISK; CLASSIFICATION; CONFERENCE PAPER; DRUG EFFECT; FEMALE; HORMONE SUBSTITUTION; HUMAN; MAJOR CLINICAL STUDY; MAMMOGRAPHY; PRIORITY JOURNAL;

EID: 0032878847     PISSN: 00029378     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9378(99)70560-0     Document Type: Conference Paper

References (26)

1. 1. Kenemans P, Barentsen R, van de Weijer P, editors. Practical HRT. Bussum, The Netherlands: Medicom; 1995.
2. 2. Beral V, Bull D, Doll R, Key T, Peto R, Reeves G, Collaborative Group on Hormonal Factors in Breast Cancer. Breast cancer and hormone replacement therapy: collaborative reanalysis of data from 51 epidemiological studies of 52,705 women with breast cancer and 108,411 women without breast cancer. Lancet 1997;350;1047-59.
3. 3. Nyström L, Rutqvist LE, Wall S, Lindgren A, Lindqvist M, Rydén S, et al. Breast cancer screening with mammography: overview of Swedish randomized trials. Lancet 1993;341:973-8.
4. 4. Kaufman Z, Garstin WIH, Hayes R, Michell MJ, Baum M. The mammographic parenchymal patterns of women on hormonal replacement therapy. Clin Radiol 1991;43:389-92.
5. 5. Leung W, Goldberg F, Zee B, Sterns E. Mammographic density in women on postmenopausal hormone replacement therapy. Surgery 1997;122:669-74.
6. 6. Persson I, Thurfjell E, Holmberg L. Effect of estrogen and estrogen-progestin replacement regimens on mammographic breast parenchymal density. J Clin Oncol 1997;15:3201-7.
7. 7. Laya MB, Larson EB, Taplin SH, White E. Effect of estrogen replacement therapy on the specificity and sensitivity of screening mammography. J Natl Cancer Inst 1996;88:643-9.
8. 8. Bland KI, Buchanan JB, Weisberg BF, Hagan TA, Gray LA. The effects of exogenous estrogen replacement therapy of the breast: breast cancer risk and mammographic parenchymal patterns. Cancer 1980;45:3027-33.
9. 9. Buchanan JB, Weisberg BF, Sandoz JP, Gray LA, Bland KI. Selected prognostic variables for mammographic parenchymal patterns. Cancer 1981;47:2135-7.
10. 10. Laya MB, Gallagher JC, Schreiman JS, Larson EB, Watson P, Weinstein L. Effects of postmenopausal hormonal replacement therapy on mammographic density and parenchymal pattern. Radiology 1995;196:433-7.
11. 11. Marugg RC, van der Mooren MJ, Hendriks JH, Rolland R, Ruijs SH. Mammographic changes in postmenopausal women on hormonal replacement therapy. Eur Radiol 1997;7:749-55.
12. 12. Wolfe JN. Breast patterns as an index of risk for developing breast cancer. AJR Am J Roentgenol 1976;126:1130-9.
13. 13. Wolfe JN. Risk for breast cancer development determined by mammographic parenchymal pattern. Cancer 1976;37: 2486-92.
14. 14. Stomper PC, Van Voorhis BJ, Ravnikar VA, Meyer JE. Mammographic changes associated with postmenopausal hormone replacement therapy: a longitudinal study. Radiology 1990;174: 498-90.
15. 15. Cyrlak D, Wong CH. Mammographic changes in postmenopausal women undergoing hormonal replacement therapy. AJR Am J Roentgenol 1993;161:1177-83.
16. 16. Söderqvist G, Isaksson E, von Schoultz B, Carlström K, Tani E, Skoog L. Proliferation of breast epithelial cells in healthy women during the menstrual cycle. Am J Obstet Gynecol 1997;176:123-8.
17. 17. Cline JM, Söderqvist G, von Schoultz B, Skoog L, von Schoultz E. Effects of hormone replacement therapy on the mammary gland of surgically postmenopausal cynomolgus macaques. Am J Obstet Gynecol 1996;174:93-100.
18. 18. Reid SE, Murthy MS, Kaufman M, Scanlon EF. Endocrine and paracrine hormones in the promotion, progression and recurrence of breast cancer. Br J Surg 1996;83:1037-46.
19. 19. Bonney RC. The role of progestins and antiprogestins in the treatment of breast cancer. Endocrinol Rel Cancer 1996;3:113-25.
20. 20. Miller WR, Langdon SP. Steroid hormones and cancer. II. Lessons from experimental systems. Eur J Surg Oncol 1997;23:163-83.
21. 21. Wren BG, Eden JA. Do progestogens reduce the risk of breast cancer? a review of the evidence. Menopause 1996;3:4-12.
22. 22. Pike MC, Spicer DV, Dahmoush L, Press MF. Estrogens, progestogens, normal breast cell proliferation, and breast cancer risk. Epidemiol Rev 1993;168:1473-80.
23. 23. Byrne C, Schairer C, Wolfe J, Parekh N, Salane M, Brinton LA, et al. Mammographic features and breast cancer risk: effects with time, age, and menopause status. J Natl Cancer Inst 1995;87:1622-9.
24. 24. Hill P. Breast density and cancer. J Natl Cancer Inst 1997;89:1721-2.
25. 25. Spicer DV, Ursin G, Parisky YR, Pearce JG, Shoupe D, Pike A, et al. Changes in mammographic densities induced by a hormonal contraceptive designed to reduce breast cancer risk. J Natl Cancer Inst 1994;86:431-6.
26. 26. McNicholas MM, Heneghan JP, Milner MH, Tunney F, Hourihane JB, MacErlaine DP. Pain and increased mammographic density in women receiving hormone replacement therapy: a prospective study. AJR Am J Roentgenol 1994;163:311-5.